High-resolution mapping of GenS3 and B11F7 epitopes on myelin-associated glycoprotein by expression PCR.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 7509375)

Published in J Neurochem on March 01, 1994

Authors

M B Tropak1, J C Roder

Author Affiliations

1: Division of Molecular Immunology and Neurobiology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Articles citing this

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95

Articles by these authors

(truncated to the top 100)

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A (1993) 20.33

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50

Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci (1997) 2.89

Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. J Neurophysiol (2001) 2.76

Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol (1978) 2.29

CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron (2001) 2.22

The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J Immunol (1979) 2.11

The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron (2001) 2.02

The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02

Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science (1998) 1.81

A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78

Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature (1984) 1.77

Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A (2000) 1.73

Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci U S A (1982) 1.73

Target-effector interaction in the natural killer cell system: isolation of target structures. Proc Natl Acad Sci U S A (1979) 1.71

Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. Scand J Immunol (1978) 1.70

Target-effector interaction in the human and murine natural killer system: specificity and xenogeneic reactivity of the solubilized natural killer-target structure complex and its loss in a somatic cell hybrid. J Exp Med (1979) 1.63

Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol (1981) 1.45

Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature (1980) 1.42

Natural killer cells. Prog Allergy (1981) 1.38

Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav (2007) 1.37

Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry (2007) 1.32

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32

Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron (1989) 1.25

Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis. J Exp Med (1982) 1.23

Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells. Nature (1982) 1.22

Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides. J Immunol (1979) 1.20

An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med (1986) 1.19

Organization of a repetitive human 1.8 kb KpnI sequence localized in the heterochromatin of chromosome 15. Chromosoma (1985) 1.19

Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src. J Neurosci (2005) 1.18

Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology (1980) 1.15

Studies of human natural killer cells. II. Analysis at the single cell level. J Immunol (1982) 1.13

A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Eur J Immunol (1979) 1.12

Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem (1997) 1.12

The biology of the human natural killer cell. J Clin Immunol (1982) 1.11

Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature (1986) 1.11

Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J Neurosci (1996) 1.11

Suppressor cells in immunosenescence. Fed Proc (1978) 1.08

Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol (1992) 1.06

Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Hybridoma (1982) 1.04

Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav (2010) 1.04

Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP. Behav Brain Res (1998) 1.03

Src potentiation of NMDA receptors in hippocampal and spinal neurons is not mediated by reducing zinc inhibition. J Neurosci (1999) 1.03

The Lurcher mutation of an alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist. J Biol Chem (2000) 1.01

Establishment of a human large cell lung tumor line (QU-DB) with metastatic properties in athymic mice. Cancer (1986) 1.01

The EBV-hybridoma technique. Methods Enzymol (1986) 1.00

Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest (1982) 1.00

Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav (2011) 1.00

Myelin-associated glycoprotein, a cell adhesion molecule of oligodendrocytes, is phosphorylated in brain. Mol Cell Biol (1988) 0.99

Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging (2000) 0.98

Differential splicing of MAG transcripts during CNS and PNS development. Brain Res (1988) 0.98

T cell activation and cellular cooperation in autoimmune NZB/NZW F hybrid mice. J Immunol (1975) 0.98

Induction of NMDA receptor-dependent long-term depression in visual cortex does not require metabotropic glutamate receptors. J Neurophysiol (1999) 0.96

Myelin-associated glycoprotein binding to gangliosides. Structural specificity and functional implications. Ann N Y Acad Sci (1998) 0.95

Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest (1994) 0.95

Regulation of the immune response in autoimmune NZB/NZW F1 mice. I. The spontaneous generation of splenic suppressor cells. Cell Immunol (1977) 0.95

Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes Brain Behav (2007) 0.94

Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells. Eur J Immunol (1990) 0.94

In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background. Int J Cancer (1980) 0.93

Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step. J Immunol (1985) 0.92

Oxygen intermediates are required for interferon activation of NK cells. J Interferon Res (1983) 0.92

An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids. J Immunol (1985) 0.91

Differential involvement of the mu and kappa opioid receptors in spatial learning. Genes Brain Behav (2003) 0.91

Synthesis of soluble myelin-associated glycoprotein in insect and mammalian cells. Gene (1989) 0.91

Regulation of the autoimmune plaque-forming cell response to single-strand DNA (sDNA) in vitro. J Immunol (1978) 0.91

Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice. Int J Cancer (1985) 0.90

Human monoclonal antibodies against Mycobacterium leprae. Infect Immun (1985) 0.89

The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice. J Neurosci (2001) 0.88

Adhesion properties of a neuronal epitope recognized by the monoclonal antibody HNK-1. Brain Res (1986) 0.87

Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci Lett (1998) 0.87

Immunological senescence. I. The role of suppressor cells. Immunology (1978) 0.87

Differential expression of the Leu-7 antigen on human lung tumor cells. Cancer Res (1985) 0.86

Regulation of myelin-associated glycoprotein binding by sialylated cis-ligands. J Neurochem (1997) 0.85

Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav (2009) 0.85

Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia. Mol Psychiatry (2011) 0.85

A comparative analysis of the phenotypic characteristics of available fusion partners for the construction of human hybridomas. Hybridoma (1983) 0.85

Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem (1995) 0.85

Localization of CNTF immunoreactivity to neurons and astroglia in the CNS. Brain Res Mol Brain Res (1994) 0.84

Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice. Genes Brain Behav (2007) 0.84

Conspecific exploration in the T-maze: abnormalities in S100 beta transgenic mice. Physiol Behav (1996) 0.84

A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines. Cancer Res (1984) 0.84

The characterization and cellular distribution of a family of antigens related to myelin associated glycoprotein in the developing nervous system. J Neuroimmunol (1985) 0.84

Are T-cell lymphomas immunocompetent? Nature (1978) 0.83

Loss of self-tolerance to single-stranded deoxyribonucleic acid (sDNA) in vitro. J Immunol (1978) 0.83

Neuronal proteoglycans: biosynthesis and functional interaction with neurons in vitro. J Neurosci (1988) 0.83

Increased CNTF gene expression in process-bearing astrocytes following injury is augmented by R(-)-deprenyl. J Neurosci Res (1994) 0.82

Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine. J Neurosci (1996) 0.82

The effect of target cell differentiation on human natural killer cell activity: a specific defect in target cell binding and early activation events. J Immunol (1982) 0.82

Double restriction in NK cell recognition is linked to transmethylation and can be triggered by asparagine-linked oligosaccharides on tumor cells. Cell Immunol (1987) 0.82

Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells. J Immunol (1987) 0.82

Selective natural killer resistance in a clone of YAC lymphoma cells. Proc Natl Acad Sci U S A (1981) 0.81

DNA amplification and tumorigenicity of the human melanoma cell line MeWo. Cancer Res (1985) 0.81

Accelerated regenerative neurite formation by a neuronal surface epitope reactive with the monoclonal antibody, Leu 7. Neurosci Lett (1985) 0.81

Memory and the effect of cold shock in the water maze in S100 beta transgenic mice. Physiol Behav (1996) 0.81

Transfection of a rat cell line with the v-Ki-ras oncogene is associated with enhanced susceptibility to natural killer cell lysis. J Exp Med (1985) 0.81

Human monoclonal antibodies. Mol Cell Biochem (1984) 0.80

Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP. J Immunol (1982) 0.80

Decreased p21 levels in anti-sense ras transfectants augments NK sensitivity. Mol Immunol (1989) 0.80

The effect of unphosphorylated and phosphorylated sugar moieties on human and mouse natural killer cell activity: is there selective inhibition at the level of target recognition and lytic acceptor site? Cell Immunol (1983) 0.80

A human hybrid myeloma for production of human monoclonal antibodies. J Immunol (1984) 0.80